Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial

Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trial

Study objective: The objective was to assess the effect of ongoing angiotensin receptor-neprilysin inhibitor(ARNI) on the effect of the sodium glucose cotransporter 2 (SGLT2) inhibitor empagliflozin on left ventricular (LV) size and function in patients with heart failure and reduced ejection fracti...

Full description

Bibliographic Details
Main Authors: Julie Hempel Larsen, Massar Omar, Jesper Jensen, Camilla Fuchs Andersen, Caroline Michaela Kistrup, Mikael Kjær Poulsen, Lars Videbæk, Finn Gustafsson, Lars Køber, Morten Schou, Jacob Eifer Møller
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:American Heart Journal Plus
Subjects:
Heart failure
Sodium-glucose cotransport 2 inhibitor
Angiotensin Receptor-Neprilysin Inhibitor
Sacubitril
Valsartan
Online Access:http://www.sciencedirect.com/science/article/pii/S2666602223000162

Internet

http://www.sciencedirect.com/science/article/pii/S2666602223000162

Similar Items